Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type (Filtration, Chromatography, Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D) - Global Forecast to 2

Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type (Filtration, Chromatography, Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D) - Forecast to 2031

The global biopharmaceutical processing equipment and consumables market was valued at $36.38 billion in 2023. This market is expected to reach $75.72 billion by 2031 from an estimated $40.22 billion in 2024, at a CAGR of 9.5% during the forecast period of 2024-2031.

After extensive secondary and primary research and in-depth analysis of the market scenario, the report identifies the key industry drivers, restraints, challenges, and opportunities. This market's growth is driven by the growing biopharmaceuticals market, biopharmaceutical plant capacity expansions, and the rising adoption of single-use bioprocessing equipment. Furthermore, emerging economies, the shift toward Bioprocessing 4.0, and the rising adoption of personalized medicines are expected to generate growth opportunities for the stakeholders in this market.

The report includes a competitive landscape based on an extensive assessment of the key strategic developments that led market participants to adopt over the past three years (2021-2024). The key players profiled in the global biopharmaceutical processing equipment and consumables market report are 3M Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies, Inc (U.S.), Repligen Corporation (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), and Solaris Biotechnology Srl (Italy).

Based on product type, the filtration systems segment is estimated to account for the largest share of the market in 2024, at 22.3%. The filtration systems are used repeatedly at every stage of the bioprocessing process, and their technological developments and repeatability are the main reasons contributing to the highest share. The development of single-use filtration systems and enhanced filtration titers are the primary areas of technological innovation in filtration.

Based on application, the market is segmented into commercial bioproduction and research bioproduction. In 2024, The commercial bioproduction segment is estimated to account for the larger share of 77.5% of the global biopharmaceutical processing equipment and consumables market to meet the growing demand for biopharmaceuticals. Biopharmaceutical companies are expanding their production capacities, developing new facilities, and moving to emerging biopharmaceutical hubs like India and Singapore, further accelerating the demand for biopharmaceutical processing equipment.

Based on end user, the global biopharmaceutical processing equipment and consumables market is categorized into pharmaceutical & biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), and academic & research institutes. The biopharmaceutical processing equipment and consumables market is expected to be dominated by the pharmaceutical & biopharmaceutical firms sector by 2024. The growing demand for biopharmaceutical goods has led to a notable surge in growth for pharmaceutical and biopharmaceutical companies in recent times, with the latter holding the biggest part of the market. The largest share of the market is also supported by initiatives taken by governments in various nations, which include funding and grants to pharmaceutical and biopharmaceutical companies for the production and R&D of biopharmaceuticals and an increase in facility expansion by major players.

An in-depth analysis of the geographical scenario of the biopharmaceutical processing equipment and consumables market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa) and covers major countries in each region.

In 2024, Europe is estimated to command the largest share of the 33.5% biopharmaceutical processing equipment and consumables market, followed by North America, Asia-Pacific, Latin America, and Middle East & Africa. The availability of top producers of consumables and equipment for biopharmaceutical processing, rising drug sales, encouragement from regulatory and governmental bodies to use biopharmaceuticals for a range of medical conditions, and a number of businesses growing both their production and operational capabilities.

Scope of the Report:

Global Biopharmaceutical Processing Equipment and Consumables Market, by Product Type

Filtration Systems
Chromatography Equipment and Consumables
Chromatography Consumables
Chromatography Equipment
Bioreactors
Reusable Bioreactors
Single-use Bioreactors
Cell Culture Products
Cell Culture Media
Cell Culture Media, by Physical Form
Dry Powder Media
Liquid Media
Cell Culture Media, by Type
Off-the-Shelf Media
Custom Media
Cell Culture Media, by Source
Chemically Defined Media
Natural Media
Reagents and Supplements
Cell and Cell Lines
Serum
Mixing Systems
Bioprocessing Containers
Sterilizers
Centrifuges
Incubators
Shakers
Biosafety Cabinets
Other Equipment and Consumables
Services

Note: Other equipment and consumables include membrane adsorbers, cell disruption reagents, pipettes, syringes, vials, closures, tubing, connectors, and sensors.

Global Biopharmaceutical Processing Equipment and Consumables Market, by Application

Commercial Bioproduction
Vaccine Manufacturing
mAb Production
Recombinant Protein Production
Cell and Gene Therapy Production
Research Bioproduction

Global Biopharmaceutical Processing Equipment and Consumables Market, by End User

Pharmaceutical and Biopharmaceutical Companies
Contract Development and Manufacturing Organizations (CDMOs)
Academic & Research Institutes

Global Biopharmaceutical Processing Equipment and Consumables Market, by Geography

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Switzerland
Denmark
Ireland
Belgium
Rest of Europe (RoE)
Asia-Pacific (APAC)
China
Japan
India
South Korea
Rest of APAC (RoAPAC)
Latin America
Middle East & Africa

Biopharmaceutical Processing Equipment and Consumables Market - Report Summary

Report Metrics	Details
Years Considered	2022 - 2031
Base Year	2023
Forecast Period	2024-2031
Page Count	294
Units Referenced	Value (USD Million)
Segments/Key Topics	Market by Product Type, Application, End User, and Geography
Regions Covered	North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa
Key Companies Mentioned	3M Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies, Inc (U.S.), Repligen Corporation (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), and Solaris Biotechnology Srl (Italy)

FAQs About the Report

What is the focus of the biopharmaceutical processing equipment and consumables market?

This study offers a detailed assessment of the biopharmaceutical processing equipment and consumables market, including the market size & forecast for various segmentations like product type, application, and end user. The biopharmaceutical processing equipment and consumables market studied in this report also involves the value analysis of various segments and sub-segments of biopharmaceutical processing equipment and consumables at regional and country levels.

What is the value of revenue generated from biopharmaceutical processing equipment and consumables across the globe? At what rate is their demand expected to grow for the next five to seven years?

The biopharmaceutical processing equipment and consumables market is projected to reach $75.72 billion by 2031, at a CAGR of 9.5% during the forecast period.

Based on product type, which biopharmaceutical processing equipment and consumables segment is estimated to hold the major share of the market?

In 2024, the filtration systems segment is estimated to account for the largest share of 22.3%, of the biopharmaceutical processing equipment and consumables market. This segment's large share is attributed to the recurring use of filtration at every step in bioprocessing and technological advancements in filtration technologies.

Which application segment is expected to grow at the highest CAGR during the forecast period?

Based on application, the commercial bioproduction segment is expected to register the highest CAGR over the forecast period. A large number of biopharmaceuticals in clinical development and nearing patent expirations of biologics are the key factors supporting the market growth.

What are the key factors supporting the growth of this market? Also, what are the major opportunities for existing market players and new entrants in the biopharmaceutical processing equipment and consumables market?

The growth of this market is mainly attributed to the global initiatives supporting the adoption of biopharmaceuticals, capacity expansions of biopharmaceutical plants, and the growing adoption of single-use bioprocessing equipment and consumables. Moreover, emerging economies, the shift towards bioprocessing 4.0, and the rising adoption of personalized medicines offer significant opportunities for market growth.

Who are the major players operating in the biopharmaceutical processing equipment and consumables market?

The key players profiled in the biopharmaceutical processing equipment and consumables market are 3M Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies, Inc (U.S.), Repligen Corporation (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), and Solaris Biotechnology Srl (Italy).

Which regions/countries are expected to offer significant growth opportunities for the market players operating in the biopharmaceutical processing equipment and consumables market?

Emerging economies like China and India are projected to offer significant growth opportunities to the market players due to the growing outsourcing of biopharmaceutical development and manufacturing, favorable government initiatives to support biopharmaceutical manufacturing, and public and private initiatives to support pharmaceutical and biopharmaceutical growth.